Sonendo, Inc. (SONX)
$0.102
Rating:
Recommendation:
-
| Symbol | SONX |
|---|---|
| Price | $0.102 |
| Beta | 2.039 |
| Volume Avg. | 0.54M |
| Market Cap | 5.536M |
| Shares () | - |
| 52 Week Range | 0.075-2.95 |
| 1y Target Est | - |
| DCF Unlevered | SONX DCF -> | |
|---|---|---|
| DCF Levered | SONX LDCF -> | |
| ROE | -101.84% | Strong Sell |
| ROA | -69.57% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 106.72% | Buy |
| P/E | -0.54 | |
| P/B | 0.25 | Neutral |
Latest SONX news
About
Download (Excel)Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.